Evidence of a role for fibroblast transient receptor potential canonical 3 Ca2+ channel in renal fibrosis

Journal of the American Society of Nephrology

Volumn 26, Issue 8, 2015, Pages 1855-1876

  Saliba, Youakim ^a   Karam, Ralph ^a   Smayra, Viviane ^a   Aftimos, Georges ^b   Abramowitz, Joel ^c   Birnbaumer, Lutz ^c   Farès, Nassim ^a  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

^b National Institute of Pathology   (Lebanon)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; FURA 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMALL INTERFERING RNA; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; CALCIUM; ISOPROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL C;

ADULT; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; FIBROBLAST; GENE SILENCING; IN VITRO STUDY; KIDNEY FIBROSIS; MALE; MOLECULAR PATHOLOGY; MYOFIBROBLAST; NONHUMAN; OBSTRUCTION-INDUCED RENAL FIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WILD TYPE MOUSE; WISTAR RAT; ANIMAL; CELL CULTURE; CYTOLOGY; FIBROSIS; KIDNEY; KNOCKOUT MOUSE; METABOLISM; MOUSE; PATHOLOGY; PHENOTYPE; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION; UPREGULATION; URETER OBSTRUCTION;

ANIMALS; CALCIUM; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBROSIS; KIDNEY; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; MYOFIBROBLASTS; PHENOTYPE; PROTEIN ISOFORMS; RATS, WISTAR; RENAL INSUFFICIENCY, CHRONIC; TRPC CATION CHANNELS; UP-REGULATION; URETERAL OBSTRUCTION;

EID: 84938922666     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014010065     Document Type: Article

References (114)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease inthe United States. JAMA 298: 2038-2047, 2007
2. Coresh J, Stevens LA, Levey AS: Chronic kidney disease is common: What do we do next? Nephrol Dial Transplant 23: 1122-1125, 2008
3. Becker GJ, Hewitson TD: The role of tubulointerstitial injury in chronic renal failure. Curr Opin Nephrol Hypertens 9: 133-138, 2000
4. Boor P, Ostendorf T, Floege J: Renal fibrosis: Novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 6: 643-656, 2010
5. Gagliardini E, Benigni A: Therapeutic potential of TGF-beta inhibition in chronic renal failure. Expert Opin Biol Ther 7: 293-304, 2007
6. Liu Y: Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney Int 69: 213-217, 2006
7. Zeisberg M, Neilson EG: Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21: 1819-1834, 2010
8. Wynn TA, Ramalingam TR: Mechanisms of fibrosis: Therapeutic translation for fibrotic disease. Nat Med 18: 1028-1040, 2012
9. Liu Y: Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15: 1-12, 2004
10. Neilson EG: Mechanisms of disease: Fibroblasts-a new look at an old problem. Nat Clin Pract Nephrol 2: 101-108, 2006
11. Wynn TA: Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210, 2008
12. Schlondorff DO: Overview of factors contributing to the pathophysi-ology of progressive renal disease. Kidney Int 74: 860-866, 2008
13. Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, Valerius MT, McMahon AP, Duffield JS: Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176: 85-97, 2010
14. Lin SL, Kisseleva T, Brenner DA, Duffield JS: Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 173: 1617-1627, 2008
15. Kriz W, Kaissling B, Le Hir M: Epithelial-mesenchymal transition (EMT) in kidney fibrosis: Fact or fantasy? J Clin Invest 121: 468-474, 2011
16. Zavadil J, Haley J, Kalluri R, Muthuswamy SK, Thompson E: Epithelial-mesenchymal transition. Cancer Res 68: 9574-9577, 2008
17. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R: Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13: 952-961, 2007
18. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R: Fibro-blasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 19: 2282-2287, 2008
19. Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R: Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 67: 10123-10128, 2007
20. Zeisberg M, Duffield JS: Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 21: 1247-1253, 2010
21. Berridge MJ: Calcium signalling remodelling and disease. Biochem Soc Trans 40: 297-309, 2012
22. Berridge MJ, Bootman MD, Roderick HL: Calcium signalling: Dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4: 517-529, 2003
23. Yue L, Xie J, Nattel S: Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res 89: 744-753, 2011
24. Clapham DE: TRP channels as cellular sensors. Nature 426: 517-524, 2003
25. Hallam TJ, Rink TJ: Agonists stimulate divalent cation channels in the plasma membrane of human platelets. FEBS Lett 186: 175-179, 1985
26. Horinouchi T, Terada K, Higa T, Aoyagi H, Nishiya T, Suzuki H, Miwa S: Function and regulation of endothelin type A receptor-operated transient receptor potential canonical channels. J Pharmacol Sci 117: 295-306, 2011
27. Liu Y, Thilo F, Kreutz R, Schulz A, Wendt N, Loddenkemper C, Jankowski V, Tepel M: Tissue expression of TRPC3 and TRPC6 in hypertensive Munich Wistar Frömter rats showing proteinuria. Am J Nephrol 31: 36-44, 2010
28. Liu D, Scholze A, Zhu Z, Kreutz R, Wehland-von-Trebra M, Zidek W, Tepel M: Increased transient receptor potential channel TRPC3 expression in spontaneously hypertensive rats. Am J Hypertens 18: 1503-1507, 2005
29. Thilo F, Scholze A, Liu DY, Zidek W, Tepel M: Association of transient receptor potential canonical type 3 (TRPC3) channel transcripts with proinflammatory cytokines. Arch Biochem Biophys 471: 57-62, 2008
30. Thilo F, Baumunk D, Krause H, Schrader M, Miller K, Loddenkemper C, Zakrzewicz A, Krueger K, Zidek W, Tepel M: Transient receptor potential canonical type 3 channels and blood pressure in humans. J Hypertens 27: 1217-1223, 2009
31. Thilo F, Loddenkemper C, Berg E, Zidek W, Tepel M: Increased TRPC3 expression in vascular endothelium of patients with malignant hypertension. Mod Pathol 22: 426-430, 2009
32. Liu Y, Krueger K, Hovsepian A, Tepel M, Thilo F: Calcium-dependent expression of transient receptor potential canonical type 3 channels in patients with chronic kidney disease. Arch Biochem Biophys 514: 44-49, 2011
33. Wang P, Liu D, Tepel M, Zhu Z: Transient receptor potential canonical type 3 channels-their evolving role in hypertension and its related complications. J Cardiovasc Pharmacol 61: 455-460, 2013
34. Adebiyi A, Thomas-Gatewood CM, Leo MD, Kidd MW, Neeb ZP, Jaggar JH: An elevation in physical coupling of type 1 inositol 1, 4, 5-trisphosphate (IP3) receptors to transient receptor potential 3 (TRPC3) channels constricts mesenteric arteries in genetic hypertension. Hypertension 60: 1213-1219, 2012
35. Zhao Z, Ni Y, Chen J, Zhong J, Yu H, Xu X, He H, Yan Z, Scholze A, Liu D, Zhu Z, Tepel M: Increased migration of monocytes in essential hypertension is associated with increased transient receptor potential channel canonical type 3 channels. PLoS ONE 7: e32628, 2012
36. Wu X, Eder P, Chang B, Molkentin JD: TRPC channels are necessary mediators of pathologic cardiac hypertrophy. Proc Natl Acad Sci USA 107: 7000-7005, 2010
37. Nakayama H, Wilkin BJ, Bodi I, Molkentin JD: Calcineurin-dependent cardiomyopathy is activated by TRPC in theadult mouse heart. FASEB J 20: 1660-1670, 2006
38. Bush EW, Hood DB, Papst PJ, Chapo JA, Minobe W, Bristow MR, Olson EN, McKinsey TA: Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling. J Biol Chem 281: 33487-33496, 2006
39. Brenner JS, Dolmetsch RE: TrpC3 regulates hypertrophy-associated gene expression without affecting myocyte beating or cell size. PLoS ONE 2: e802, 2007
40. Sabourin J, Robin E, Raddatz E: A key role of TRPC channels in the regulation of electromechanical activity of the developing heart. Cardiovasc Res 92: 226-236, 2011
41. Sabourin J, Antigny F, Robin E, Frieden M, Raddatz E: Activation of transientreceptor potential canonical3 (TRPC3)-mediated Ca2+ entry by A1 adenosine receptor in cardiomyocytes disturbs atrioventricular conduction. J Biol Chem 287: 26688-26701, 2012
42. Kiyonaka S, Kato K, Nishida M, Mio K, Numaga T, Sawaguchi Y, Yoshida T, Wakamori M, Mori E, Numata T, Ishii M, Takemoto H, Ojida A, Watanabe K, Uemura A, Kurose H, Morii T, Kobayashi T, Sato Y, Sato C, Hamachi I, Mori Y: Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound. Proc Natl Acad Sci USA 106: 5400-5405, 2009
43. 1H-pyrazole-4-carboxylate (Pyr3), prevents stent-induced arterial remodeling. J Pharmacol Exp Ther 344: 33-40, 2013
44. Harada M, Luo X, Qi XY, Tadevosyan A, Maguy A, Ordog B, Ledoux J, Kato T, Naud P, Voigt N, Shi Y, Kamiya K, Murohara T, Kodama I, Tardif JC, Schotten U, Van Wagoner DR, Dobrev D, Nattel S: Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation 126: 2051-2064, 2012
45. Ikeda K, Nakajima T, Yamamoto Y, Takano N, Tanaka T, Kikuchi H, Oguri G, Morita T, Nakamura F, Komuro I: Roles of transient receptor potential canonical (TRPC) channels and reverse-mode Na+/Ca2+ exchanger on cell proliferation in human cardiac fibroblasts: Effects of transforming growth factor b1. Cell Calcium 54: 213-225, 2013
46. Almirza WH, Peters PH, van Zoelen EJ, Theuvenet AP: Role of Trpc channels, Stim1 and Orai1 in PGF(2a)-induced calcium signaling in NRK fibroblasts. Cell Calcium 51: 12-21, 2012
47. Dernison MM, Almirza WH, Kusters JM, van Meerwijk WP, Gielen CC, van Zoelen EJ, Theuvenet AP: Growth-dependent modulation of ca-pacitative calciumentry in normal rat kidneyfibroblasts. Cell Signal 22: 1044-1053, 2010
48. Goel M, Sinkins WG, Zuo CD, Estacion M, Schilling WP: Identification and localization ofTRPC channels in the rat kidney. Am J Physiol Renal Physiol 290: F1241-F1252, 2006
49. Facemire CS, Mohler PJ, Arendshorst WJ: Expression and relative abundance of short transient receptor potential channels in the rat renal microcirculation. Am J Physiol Renal Physiol 286: F546-F551, 2004
50. Woudenberg-Vrenken TE, Bindels RJ, Hoenderop JG: The role of transient receptor potential channels in kidney disease. Nat Rev Nephrol 5: 441-449, 2009
51. Letavernier E, Rodenas A, Guerrot D, Haymann JP: Williams-Beuren syndrome hypercalcemia: Is TRPC3 a novel mediator in calcium ho-meostasis? Pediatrics 129: e1626-e1630, 2012
52. Goel M, Schilling WP: Role of TRPC3 channels in ATP-induced Ca2+ signaling in principal cells of the inner medullary collecting duct. Am J Physiol Renal Physiol 299: F225-F233, 2010
53. Goel M, Zuo CD, Schilling WP: RoleofcAMP/PKA signalingcascade in vasopressin-induced trafficking of TRPC3 channels in principal cells of the collecting duct. Am J Physiol Renal Physiol 298: F988-F996, 2010
54. Goel M, Sinkins WG, Zuo CD, Hopfer U, Schilling WP: Vasopressin-induced membranetrafficking of TRPC3 and AQP2channels in cellsof the rat renal collecting duct. Am J Physiol Renal Physiol 293: F1476-F1488, 2007
55. Chevalier RL, Forbes MS, Thornhill BA: Ureteralobstructionas amodel of renal interstitial fibrosis andobstructive nephropathy. Kidney Int 75: 1145-1152, 2009
56. Vaughan ED Jr., Marion D, Poppas DP, Felsen D: Pathophysiology of unilateral ureteral obstruction: Studies from Charlottesville to New York. J Urol 172: 2563-2569, 2004
57. Klahr S, Morrissey J: Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283: F861-F875, 2002
58. Kim DH, Moon SO, Jung YJ, Lee AS, Kang KP, Lee TH, Lee S, Chai OH, Song CH, Jang KY, Sung MJ, Zhang X, Park SK, Kim W: Mast cells decrease renal fibrosis in unilateral ureteral obstruction. Kidney Int 75: 1031-1038, 2009
59. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G: Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 397: 259-263, 1999
60. Venkatachalam K, Zheng F, Gill DL: Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C. J Biol Chem 278: 29031-29040, 2003
61. Bird GS, DeHaven WI, Smyth JT, Putney JW Jr.: Methods for studying store-operated calcium entry. Methods 46: 204-212, 2008
62. Anderson M: Mn ions pass through calcium channels. A possible explanation. J Gen Physiol 81: 805-827, 1983
63. Scumpia PO, McAuliffe PF, O'Malley KA, Ungaro R, Uchida T, Matsumoto T, Remick DG, Clare-Salzler MJ, Moldawer LL, Efron PA: CD11c+ dendritic cells are required for survival in murine poly-microbial sepsis. J Immunol 175: 3282-3286, 2005
64. Krüger T, Benke D, Eitner F, Lang A, Wirtz M, Hamilton-Williams EE, Engel D, Giese B, Müller-Newen G, Floege J, Kurts C: Identification and functional characterization of dendritic cells in the healthy murine kidney and inexperimental glomerulonephritis. J Am Soc Nephrol 15: 613-621, 2004
65. Whyte DA, Li C, Thomson RB, Nix SL, Zanjani R, Karp SL, Aronson PS, Igarashi P: Ksp-cadherin gene promoter. I. Characterization and renal epithelial cell-specific activity. Am J Physiol 277: F587-F598, 1999
66. Pusztaszeri MP, Seelentag W, Bosman FT: Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 54: 385-395, 2006
67. Pilling D, Fan T, Huang D, Kaul B, Gomer RH: Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, mac-rophages, and fibroblasts. PLoS ONE 4: e7475, 2009
68. Klco JM, Kulkarni S, Kreisel FH, Nguyen TD, Hassan A, Frater JL: Im-munohistochemical analysis of monocytic leukemias: Usefulness of CD14 and Kruppel-like factor 4, a novel monocyte marker. Am J Clin Pathol 135: 720-730, 2011
69. Ilan N, Cheung L, Pinter E, Madri JA: Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation. J Biol Chem 275: 21435-21443, 2000
70. Hartmann J, Dragicevic E, Adelsberger H, Henning HA, Sumser M, Abramowitz J, Blum R, Dietrich A, Freichel M, Flockerzi V, Birnbaumer L, Konnerth A: TRPC3 channels are required for synaptic transmission and motor coordination. Neuron 59: 392-398, 2008
71. Strutz F, Zeisberg M: Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 17: 2992-2998, 2006
72. Wolf G: Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int 70: 1914-1919, 2006
73. Ruiz-Ortega M, Rupérez M, Esteban V, Rodríguez-Vita J, Sánchez-López E, Carvajal G, Egido J: Angiotensin II: A key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 21: 16-20, 2006
74. Pimentel JL Jr., Montero A, Wang S, Yosipiv I, el-Dahr S, Martínez-Maldonado M: Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction. Kidney Int 48: 1247-1253, 1995
75. Satoh M, Kashihara N, Yamasaki Y, Maruyama K, Okamoto K, Maeshima Y, Sugiyama H, Sugaya T, Murakami K, Makino H: Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 12: 317-325, 2001
76. Pimentel JL Jr., Wang S, Martinez-Maldonado M: Regulation of the renal angiotensin II receptor gene in acute unilateral ureteral obstruction. Kidney Int 45: 1614-1621, 1994
77. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S: Angiotensin II receptor antagonist ameliorates renaltubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47: 1285-1294, 1995
78. Abramowitz J, Birnbaumer L: Physiology and pathophysiology of canonical transient receptor potential channels. FASEB J 23: 297-328, 2009
79. Earley S, Gonzales AL: (Sub)family feud: Crosstalk between TRPC channels in vascular smooth muscle cells during vasoconstrictor agonist stimulation. J Physiol 588: 3637-3638, 2010
80. Hopf FW, Turner PR, Denetclaw WF Jr., Reddy P, Steinhardt RA: A critical evaluation of resting intracellular free calcium regulation in dystrophic mdx muscle. Am J Physiol 271: C1325-C1339, 1996
81. Parekh AB, Penner R: Store depletion and calcium influx. Physiol Rev 77: 901-930, 1997
82. Numaga T, Nishida M, Kiyonaka S, Kato K, Katano M, Mori E, Kurosaki T, Inoue R, Hikida M, Putney JW Jr., Mori Y: Ca2+ influx and protein scaffolding via TRPC3 sustain PKCbeta and ERK activation in B cells. J Cell Sci 123: 927-938, 2010
83. Olson ER, Shamhart PE, Naugle JE, Meszaros JG: Angiotensin II-induced extracellular signal-regulated kinase 1/2 activation is mediated by protein kinase Cdelta and intracellular calcium in adult rat cardiac fibroblasts. Hypertension 51: 704-711, 2008
84. Schorb W, Conrad KM, Singer HA, Dostal DE, Baker KM: Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts. J Mol Cell Cardiol 27: 1151-1160, 1995
85. Stockand JD, Meszaros JG: Aldosterone stimulates proliferation of cardiacfibroblastsbyactivating Ki-RasA and MAPK1/2 signaling. Am J Physiol Heart Circ Physiol 284: H176-H184, 2003
86. Liu Y: Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7: 684-696, 2011
87. Davis J, Burr AR, Davis GF, Birnbaumer L, Molkentin JD: A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. Dev Cell 23: 705-715, 2012
88. Carter AB, Monick MM, Hunninghake GW: Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol 20: 751-758, 1999
89. Nagai Y, Miyata K, Sun GP, Rahman M, Kimura S, Miyatake A, Kiyomoto H, Kohno M, Abe Y, Yoshizumi M, Nishiyama A: Aldo-sterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Hypertension 46: 1039-1045, 2005
90. Rokosova B, Bentley JP: Effect of calcium on cell proliferation and extracellular matrix synthesis in arterial smooth muscle cells and dermal fibroblasts. Exp Mol Pathol 44: 307-317, 1986
91. Zhu B, Wang YJ, Zhu CF, Lin Y, Zhu XL, Wei S, Lu Y, Cheng XX: Triptolide inhibits extracellular matrix protein synthesis by suppressing the Smad2 but not the MAPK pathway in TGF-beta1-stimulated NRK-49F cells. Nephrol Dial Transplant 25: 3180-3191, 2010
92. Earley S: Molecular diversity ofreceptor operated channels in vascular smooth muscle: A role for heteromultimeric TRP channels? Circ Res 98: 1462-1464, 2006
93. Gudermann T, Hofmann T, Mederos y Schnitzler M, Dietrich A: Activation, subunit composition and physiological relevance of DAG-sensitive TRPC proteins. Novartis Found Symp 258: 103-118, 2004
94. Goel M, Sinkins WG, Schilling WP: Selective association of TRPC channel subunits in rat brain synaptosomes. J Biol Chem 277: 48303-48310, 2002
95. Dietrich A, Mederos Y Schnitzler M, Gollasch M, Gross V, Storch U, Dubrovska G, Obst M, Yildirim E, Salanova B, Kalwa H, Essin K, Pinkenburg O, Luft FC, Gudermann T, Birnbaumer L: Increased vascular smooth muscle contractility in TRPC6-/-mice. Mol Cell Biol 25: 6980-6989, 2005
96. Li SW, Westwick J, Poll CT: Receptor-operated Ca2+ influxchannels in leukocytes: A therapeutic target? Trends Pharmacol Sci 23: 63-70, 2002
97. Nilius B, Owsianik G, Voets T, Peters JA: Transient receptor potential cation channels in disease. Physiol Rev 87: 165-217, 2007
98. Storch U, Forst AL, Philipp M, Gudermann T, Mederos y Schnitzler M: Transient receptor potential channel 1 (TRPC1) reduces calcium permeability in heteromeric channel complexes. J Biol Chem 287: 3530-3540, 2012
99. Kuwahara K, Wang Y, McAnally J, Richardson JA, Bassel-Duby R, Hill JA, Olson EN: TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin Invest 116: 3114-3126, 2006
100. Pat B, Yang T, Kong C, Watters D, Johnson DW, Gobe G: Activation of ERK in renal fibrosis after unilateral ureteral obstruction: Modulation by antioxidants. Kidney Int 67: 931-943, 2005
101. Rodríguez-Peña AB, Grande MT, Eleno N, Arévalo M, Guerrero C, Santos E, López-Novoa JM: Activation of Erk1/2 and Akt following unilateral ureteral obstruction. Kidney Int 74: 196-209, 2008
102. Fu P, Liu F, Su S, Wang W, Huang XR, Entman ML, Schwartz RJ, Wei L, Lan HY: Signaling mechanism of renal fibrosis in unilateral ureteral obstructive kidney disease in ROCK1 knockout mice. J Am Soc Nephrol 17: 3105-3114, 2006
103. Johnson DW, Saunders HJ, Baxter RC, Field MJ, Pollock CA: Paracrine stimulation of human renal fibroblasts byproximaltubule cells. Kidney Int 54: 747-757, 1998
104. Johnson DW, Saunders HJ, Brew BK, Ganesan A, Baxter RC, Poronnik P, Cook DI, Györy AZ, Field MJ, Pollock CA: Human renal fibroblasts modulate proximal tubule cell growth and transport via the IGF-I axis. Kidney Int 52: 1486-1496, 1997
105. Johnson DW, Saunders HJ, Johnson FJ, Huq SO, Field MJ, Pollock CA: Cyclosporin exerts a direct fibrogenic effect on human tubu-lointerstitial cells: Roles of insulin-like growth factor I, transforming growth factor beta1, and platelet-derived growth factor. J Pharmacol Exp Ther 289: 535-542, 1999
106. Kelynack KJ, Hewitson TD, Nicholls KM, Darby IA, Becker GJ: Human renal fibroblast contraction of collagen I lattices is an integrin-mediated process. Nephrol Dial Transplant 15: 1766-1772, 2000
107. Masterson R, Hewitson TD, Kelynack K, Martic M, Parry L, Bathgate R, Darby I, Becker G: Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro. Nephrol Dial Transplant 19: 544-552, 2004
108. Shivakumar K, Kumaran C: L-type calcium channel blockers and EGTA enhance superoxide production in cardiac fibroblasts. J Mol Cell Cardiol 33: 373-377, 2001
109. Soldatov NM: Molecular diversity of L-type Ca2+ channel transcripts in human fibroblasts. Proc Natl Acad Sci USA 89: 4628-4632, 1992
110. Yang S, Huang XY: Ca2+ influx throughL-typeCa2+ channels controls the trailing tail contraction in growth factor-induced fibroblast cell migration. J Biol Chem 280: 27130-27137, 2005
111. Zhu DL, Hérembert T, Caruelle D, Caruelle JP, Marche P: Involvement of calcium channels in fibroblast growth factor-induced activation of arterial cells in spontaneously hypertensive rats. J Cardiovasc Pharmacol 23: 395-400, 1994
112. Grynkiewicz G, Poenie M, Tsien RY: A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985
113. Cerella C, Coppola S, Maresca V, De Nicola M, Radogna F, Ghibelli L: Multiple mechanisms for hydrogen peroxide-induced apoptosis. Ann N Y Acad Sci 1171: 559-563, 2009
114. McKeague AL, Wilson DJ, Nelson J: Staurosporine-inducedapoptosis and hydrogen peroxide-induced necrosis in two human breast cell lines. Br J Cancer 88: 125-131, 2003